APH 7.53% 43.0¢ australian primary hemp limited

abraxis valuation multiples.

  1. 10,009 Posts.
    "we could very quickly have multiples of ABRAXIS valuation." Pete Smith.

    That is a big call considering ABRAXANE was valued at $3Bn dollars.

    How clever was. ACL board to buy this project for $10 million back in 06.

    So we have our answer in 20 months from now and then can quickly lead on from Collectoral Cancer to several other forms. So if Phase 3 is successful we can quickly move to other indications.

    That means if this trial is successful and that looks highly likely, we should in theory move towards a $10Bn market cap withing five years.

    That is roughly $45 - $50 per share. We should not be diluting because of the FONDA cash flow.

    This scenario should become clearer soon.

 
watchlist Created with Sketch. Add APH (ASX) to my watchlist
(20min delay)
Last
43.0¢
Change
-0.035(7.53%)
Mkt cap ! $44.45M
Open High Low Value Volume
46.0¢ 46.0¢ 42.5¢ $67.62K 152.8K

Buyers (Bids)

No. Vol. Price($)
2 30740 43.0¢
 

Sellers (Offers)

Price($) Vol. No.
44.0¢ 2132 2
View Market Depth
Last trade - 15.56pm 25/02/2021 (20 minute delay) ?
(live)
Last
43.0¢
  Change
-0.035 ( 5.49 %)
Open High Low Volume
44.0¢ 44.0¢ 43.0¢ 30373
Last updated 15.49pm 25/02/2021 (live) ?
APH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.